ENSG00000105974


Homo sapiens

Features
Gene ID: ENSG00000105974
  
Biological name :CAV1
  
Synonyms : CAV1 / caveolin 1 / Q03135
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 7
Strand: 1
Band: q31.2
Gene start: 116524785
Gene end: 116561184
  
Corresponding Affymetrix probe sets: 203065_s_at (Human Genome U133 Plus 2.0 Array)   212097_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000377113
Ensembl peptide - ENSP00000384348
Ensembl peptide - ENSP00000479447
Ensembl peptide - ENSP00000409541
Ensembl peptide - ENSP00000389033
Ensembl peptide - ENSP00000339191
Ensembl peptide - ENSP00000377110
Ensembl peptide - ENSP00000377111
NCBI entrez gene - 857     See in Manteia.
OMIM - 601047
RefSeq - NM_001753
RefSeq - NM_001172895
RefSeq - NM_001172896
RefSeq - NM_001172897
RefSeq Peptide - NP_001166366
RefSeq Peptide - NP_001166367
RefSeq Peptide - NP_001166368
RefSeq Peptide - NP_001744
swissprot - Q2TNI1
swissprot - C9JKI3
swissprot - A0A024R757
swissprot - F8WDM7
swissprot - Q03135
swissprot - E9PCT5
Ensembl - ENSG00000105974
  
Related genetic diseases (OMIM): 606721 - ?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721
  612526 - ?Lipodystrophy, congenital generalized, type 3, 612526
  615343 - Pulmonary hypertension, primary, 3, 615343
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 cav1ENSDARG00000103747Danio rerio
 CAV1ENSGALG00000043287Gallus gallus
 Cav1ENSMUSG00000007655Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
CAV3 / P56539 / caveolin 3ENSG0000018253354
CAV2 / P51636 / caveolin 2ENSG0000010597131


Protein motifs (from Interpro)
Interpro ID Name
 IPR001612  Caveolin
 IPR015504  Caveolin-1
 IPR018361  Caveolin, conserved site


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0000122 negative regulation of transcription by RNA polymerase II ISS
 biological_processGO:0000188 inactivation of MAPK activity ISS
 biological_processGO:0001525 angiogenesis IEA
 biological_processGO:0001570 vasculogenesis ISS
 biological_processGO:0001666 response to hypoxia ISS
 biological_processGO:0001937 negative regulation of endothelial cell proliferation ISS
 biological_processGO:0001960 negative regulation of cytokine-mediated signaling pathway IEA
 biological_processGO:0002026 regulation of the force of heart contraction IEA
 biological_processGO:0002931 response to ischemia IEA
 biological_processGO:0003057 regulation of the force of heart contraction by chemical signal IEA
 biological_processGO:0006641 triglyceride metabolic process ISS
 biological_processGO:0006816 calcium ion transport ISS
 biological_processGO:0006874 cellular calcium ion homeostasis ISS
 biological_processGO:0006940 regulation of smooth muscle contraction ISS
 biological_processGO:0007519 skeletal muscle tissue development ISS
 biological_processGO:0007595 lactation IEA
 biological_processGO:0008104 protein localization ISS
 biological_processGO:0008285 negative regulation of cell proliferation IEA
 biological_processGO:0009617 response to bacterium IDA
 biological_processGO:0009968 negative regulation of signal transduction IEA
 biological_processGO:0010524 positive regulation of calcium ion transport into cytosol ISS
 biological_processGO:0010608 posttranscriptional regulation of gene expression IEA
 biological_processGO:0010628 positive regulation of gene expression IEA
 biological_processGO:0010952 positive regulation of peptidase activity IEA
 biological_processGO:0016032 viral process IEA
 biological_processGO:0016050 vesicle organization ISS
 biological_processGO:0019065 receptor-mediated endocytosis of virus by host cell IGI
 biological_processGO:0019217 regulation of fatty acid metabolic process ISS
 biological_processGO:0019915 lipid storage ISS
 biological_processGO:0030193 regulation of blood coagulation IMP
 biological_processGO:0030301 cholesterol transport TAS
 biological_processGO:0030512 negative regulation of transforming growth factor beta receptor signaling pathway IDA
 biological_processGO:0030857 negative regulation of epithelial cell differentiation ISS
 biological_processGO:0030879 mammary gland development ISS
 biological_processGO:0031295 T cell costimulation IDA
 biological_processGO:0031397 negative regulation of protein ubiquitination IMP
 biological_processGO:0031398 positive regulation of protein ubiquitination IMP
 biological_processGO:0031623 receptor internalization IDA
 biological_processGO:0032091 negative regulation of protein binding IDA
 biological_processGO:0032092 positive regulation of protein binding IMP
 biological_processGO:0032507 maintenance of protein location in cell ISS
 biological_processGO:0032570 response to progesterone IDA
 biological_processGO:0033137 negative regulation of peptidyl-serine phosphorylation IDA
 biological_processGO:0033138 positive regulation of peptidyl-serine phosphorylation IDA
 biological_processGO:0033484 nitric oxide homeostasis ISS
 biological_processGO:0034141 positive regulation of toll-like receptor 3 signaling pathway IMP
 biological_processGO:0042310 vasoconstriction IEA
 biological_processGO:0042532 negative regulation of tyrosine phosphorylation of STAT protein IEA
 biological_processGO:0042632 cholesterol homeostasis TAS
 biological_processGO:0043085 positive regulation of catalytic activity ISS
 biological_processGO:0043407 negative regulation of MAP kinase activity IEA
 biological_processGO:0043409 negative regulation of MAPK cascade ISS
 biological_processGO:0043627 response to estrogen IDA
 biological_processGO:0044860 protein localization to plasma membrane raft ISS
 biological_processGO:0045019 negative regulation of nitric oxide biosynthetic process ISS
 biological_processGO:0045907 positive regulation of vasoconstriction ISS
 biological_processGO:0046426 negative regulation of JAK-STAT cascade ISS
 biological_processGO:0048550 negative regulation of pinocytosis IMP
 biological_processGO:0050900 leukocyte migration TAS
 biological_processGO:0050999 regulation of nitric-oxide synthase activity TAS
 biological_processGO:0051001 negative regulation of nitric-oxide synthase activity IEA
 biological_processGO:0051259 protein complex oligomerization IEA
 biological_processGO:0051260 protein homooligomerization ISS
 biological_processGO:0051480 regulation of cytosolic calcium ion concentration IDA
 biological_processGO:0051592 response to calcium ion ISS
 biological_processGO:0051899 membrane depolarization ISS
 biological_processGO:0052547 regulation of peptidase activity ISS
 biological_processGO:0055074 calcium ion homeostasis ISS
 biological_processGO:0060056 mammary gland involution ISS
 biological_processGO:0060355 positive regulation of cell adhesion molecule production IMP
 biological_processGO:0060546 negative regulation of necroptotic process IEA
 biological_processGO:0061099 negative regulation of protein tyrosine kinase activity IMP
 biological_processGO:0070836 caveola assembly ISS
 biological_processGO:0071360 cellular response to exogenous dsRNA IMP
 biological_processGO:0071375 cellular response to peptide hormone stimulus ISS
 biological_processGO:0071455 cellular response to hyperoxia IMP
 biological_processGO:0071560 cellular response to transforming growth factor beta stimulus IEA
 biological_processGO:0072584 caveolin-mediated endocytosis IDA
 biological_processGO:0086091 regulation of heart rate by cardiac conduction ISS
 biological_processGO:0086098 angiotensin-activated signaling pathway involved in heart process ISS
 biological_processGO:0090090 negative regulation of canonical Wnt signaling pathway ISS
 biological_processGO:0090263 positive regulation of canonical Wnt signaling pathway IMP
 biological_processGO:0097190 apoptotic signaling pathway IMP
 biological_processGO:0098903 regulation of membrane repolarization during action potential IMP
 biological_processGO:0098909 regulation of cardiac muscle cell action potential involved in regulation of contraction IC
 biological_processGO:0098911 regulation of ventricular cardiac muscle cell action potential ISS
 biological_processGO:1900027 regulation of ruffle assembly IDA
 biological_processGO:1900085 negative regulation of peptidyl-tyrosine autophosphorylation IMP
 biological_processGO:1901380 negative regulation of potassium ion transmembrane transport IMP
 biological_processGO:1901844 regulation of cell communication by electrical coupling involved in cardiac conduction ISS
 biological_processGO:1903071 positive regulation of ER-associated ubiquitin-dependent protein catabolic process IC
 biological_processGO:1903361 protein localization to basolateral plasma membrane ISS
 biological_processGO:1903598 positive regulation of gap junction assembly ISS
 biological_processGO:1903609 negative regulation of inward rectifier potassium channel activity IMP
 biological_processGO:1904886 beta-catenin destruction complex disassembly TAS
 biological_processGO:2000286 receptor internalization involved in canonical Wnt signaling pathway IMP
 biological_processGO:2000535 regulation of entry of bacterium into host cell IDA
 biological_processGO:2000811 negative regulation of anoikis IMP
 biological_processGO:2001238 positive regulation of extrinsic apoptotic signaling pathway IMP
 biological_processGO:2001244 positive regulation of intrinsic apoptotic signaling pathway IMP
 cellular_componentGO:0000139 Golgi membrane IDA
 cellular_componentGO:0002080 acrosomal membrane IEA
 cellular_componentGO:0005622 intracellular IDA
 cellular_componentGO:0005768 endosome IDA
 cellular_componentGO:0005783 endoplasmic reticulum IDA
 cellular_componentGO:0005789 endoplasmic reticulum membrane TAS
 cellular_componentGO:0005794 Golgi apparatus IEA
 cellular_componentGO:0005811 lipid droplet TAS
 cellular_componentGO:0005886 plasma membrane TAS
 cellular_componentGO:0005887 integral component of plasma membrane IEA
 cellular_componentGO:0005901 caveola IDA
 cellular_componentGO:0005925 focal adhesion IDA
 cellular_componentGO:0005929 cilium IEA
 cellular_componentGO:0005938 cell cortex IEA
 cellular_componentGO:0016020 membrane IDA
 cellular_componentGO:0016021 integral component of membrane IEA
 cellular_componentGO:0030666 endocytic vesicle membrane TAS
 cellular_componentGO:0031410 cytoplasmic vesicle IDA
 cellular_componentGO:0031901 early endosome membrane TAS
 cellular_componentGO:0032991 protein-containing complex IDA
 cellular_componentGO:0034098 VCP-NPL4-UFD1 AAA ATPase complex IPI
 cellular_componentGO:0045121 membrane raft IEA
 cellular_componentGO:0048471 perinuclear region of cytoplasm ISS
 molecular_functionGO:0005102 signaling receptor binding IPI
 molecular_functionGO:0005113 patched binding NAS
 molecular_functionGO:0005198 structural molecule activity IDA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0015485 cholesterol binding TAS
 molecular_functionGO:0016504 peptidase activator activity ISS
 molecular_functionGO:0019899 enzyme binding IPI
 molecular_functionGO:0019901 protein kinase binding IPI
 molecular_functionGO:0030674 protein binding, bridging IEA
 molecular_functionGO:0032947 protein-containing complex scaffold activity TAS
 molecular_functionGO:0042802 identical protein binding IPI
 molecular_functionGO:0044325 ion channel binding IPI
 molecular_functionGO:0046982 protein heterodimerization activity IEA
 molecular_functionGO:0048365 Rac GTPase binding IPI
 molecular_functionGO:0050998 nitric-oxide synthase binding IPI
 molecular_functionGO:0051117 ATPase binding IPI
 molecular_functionGO:0070320 inward rectifier potassium channel inhibitor activity IDA


Pathways (from Reactome)
Pathway description
Triglyceride catabolism
eNOS activation
NOSTRIN mediated eNOS trafficking
Basigin interactions
Disassembly of the destruction complex and recruitment of AXIN to the membrane
VEGFR2 mediated vascular permeability


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000083 Renal failure 
Show

 HP:0000112 Nephropathy "A nonspecific term referring to disease or damage of the kidneys." [HPO:curators]
Show

 HP:0000141 Amenorrhea 
Show

 HP:0000147 polycystic ovaries 
Show

 HP:0000163 Abnormality of the oral cavity "Abnormality of the opening or hollow part of the mouth." [HPO:curators]
Show

 HP:0000217 Xerostomia "Dryness of the mouth due to salivary gland dysfunction." [HPO:curators]
Show

 HP:0000271 Abnormality of the face 
Show

 HP:0000303 Mandibular prognathia "Abnormal prominence of the chin related to an abnormally long mandible." [HPO:curators]
Show

 HP:0000336 Prominent supraorbital ridges "Abnormal prominence of the supraorbital ridges, which are bony ridge located above the eye sockets in the area of the eyebrows." [HPO:curators]
Show

 HP:0000519 Congenital cataract "A congenital `cataract` (HP:0000518)." [HPO:probinson]
Show

 HP:0000580 Pigmentary retinopathy 
Show

 HP:0000639 Nystagmus "Rhythmic, involuntary oscillations of one or both eyes related to abnormality in fixation, conjugate gaze, or vestibular mechanisms." [HPO:curators]
Show

 HP:0000670 Carious teeth 
Show

 HP:0000819 Diabetes mellitus 
Show

 HP:0000826 Precocious puberty "The onset of secondary sexual characteristics before a normal age. Although it is difficult to define normal age ranges because of the marked variation with which puberty begins in normal children, precocious puberty can be defined as the onset of puberty before the age of 8 years in girls or 9 years in boys." [HPO:curators]
Show

 HP:0000833 Glucose intolerance 
Show

 HP:0000842 Hyperinsulinemia 
Show

 HP:0000845 Acromegaly "Acromegaly is a condition resulting from overproduction of growth hormone by the pituitary gland in persons with closed epiphyses, and consists chiefly in the enlargement of the distal parts of the body. The circumference of the skull increases, the nose becomes broad, the tongue becomes enlarged, the facial features become coarsened, the mandible grows excessively, and the teeth become separated. The fingers and toes grow chiefly in thickness." [HPO:curators]
Show

 HP:0000855 Insulin resistance 
Show

 HP:0000876 Oligomenorrhea 
Show

 HP:0000956 Acanthosis nigricans 
Show

 HP:0000975 Hyperhidrosis "An abnormally increased perspiration." [HPO:probinson]
Show

 HP:0001000 Abnormality of skin pigmentation 
Show

 HP:0001007 Hirsutism "Abnormally increased hair growth." [HPO:curators]
Show

 HP:0001053 Hypopigmented skin patches 
Show

 HP:0001176 Large hands 
Show

 HP:0001249 Mental retardation 
Show

 HP:0001278 Orthostatic hypotension "A form of hypotension characterized by a sudden fall in blood pressure that occurs when a person assumes a standing position." [HPO:curators]
Show

 HP:0001310 Dysmetria 
Show

 HP:0001324 Muscle weakness "Reduced strength of muscles." [HPO:curators]
Show

 HP:0001369 Arthritis 
Show

 HP:0001371 Contractures 
Show

 HP:0001394 Cirrhosis 
Show

 HP:0001397 Hepatic steatosis 
Show

 HP:0001399 Hepatic failure 
Show

 HP:0001433 Hepatosplenomegaly 
Show

 HP:0001635 Congestive heart failure "The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction." [HPO:curators]
Show

 HP:0001639 Hypertrophic cardiomyopathy 
Show

 HP:0001658 Myocardial infarction 
Show

 HP:0001733 Pancreatitis 
Show

 HP:0001769 Broad feet "Increased width of the feet." [HPO:curators]
Show

 HP:0002015 Dysphagia "Difficulty in swallowing." [HPO:curators]
Show

 HP:0002017 Nausea and vomiting 
Show

 HP:0002020 Gastroesophageal reflux 
Show

 HP:0002024 Malabsorption 
Show

 HP:0002066 Gait ataxia "Impairment of the ability to coordinate the movements required for normal walking." [HPO:curators]
Show

 HP:0002092 Pulmonary hypertension 
Show

 HP:0002094 Dyspnea 
Show

 HP:0002113 Pulmonary infiltrates 
Show

 HP:0002119 Ventriculomegaly 
Show

 HP:0002155 Hypertriglyceridemia 
Show

 HP:0002169 Clonus 
Show

 HP:0002206 Pulmonary fibrosis 
Show

 HP:0002230 Generalized hirsutism "Abnormally increased hair growth over much of the entire body." [HPO:curators]
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002721 Immunodeficiency 
Show

 HP:0002757 Recurrent fractures "The repeated occurence of bone fractures (implying an abnormally increased tendency for fracture)." [HPO:curators]
Show

 HP:0002797 Osteolysis 
Show

 HP:0002829 Arthralgia 
Show

 HP:0002901 Hypocalcemia "A level of blood calcium that is lower than normal." [HPO:curators]
Show

 HP:0002936 Distal sensory impairment 
Show

 HP:0002960 Autoimmune disease 
Show

 HP:0003124 Hypercholesterolemia 
Show

 HP:0003487 Babinski sign "Upturning of the big toe (and sometimes fanning of the other toes) in response to stimulation of the sole of the foot. If the Babinski sign is present it can indicate damage to the corticospinal tract." [HPO:curators]
Show

 HP:0003635 Loss of subcutaneous adipose tissue in limbs 
Show

 HP:0003712 Muscle hypertrophy "Hypertrophy (increase in size) of muscle cells (as opposed to hyperplasia, which refers to an increase in the number of muscle cells)." [HPO:curators]
Show

 HP:0003758 Reduced subcutaneous adipose tissue "The presence of an abnormally reduced amount of subcutaneous adipose tissue." [HPO:curators]
Show

 HP:0003828 Variable expressivity 
Show

 HP:0003829 Incomplete penetrance 
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0004890 elevated pulmonary artery pressure 
Show

 HP:0005317 Increased pulmonary vascular resistance 
Show

 HP:0005320 Lack of facial subcutaneous fat 
Show

 HP:0005616 Accelerated skeletal maturation "An abnormally increased rate of skeletal maturation. Accelerated skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body." [HPO:curators]
Show

 HP:0005995 Decreased adipose tissue around neck 
Show

 HP:0007340 Lower limb muscle weakness "Weakness of the muscles of the legs." [HPO:curators]
Show

 HP:0007485 Absence of subcutaneous fat 
Show

 HP:0008366 Contractures involving the joints of the feet 
Show

 HP:0009125 Lipodystrophy "Degenerative changes of the fat tissue." [HPO:curators]
Show

 HP:0009473 Joint contractures involving the joints of the hand 
Show

 HP:0009830 Peripheral neuropathy "Peripheral neuropathy is a general term for any disorder of the peripheral nervous system. The main clinical features used to classify peripheral neuropathy are distribution, type (mainly demyelinating versus mainly axonal), duration, and course." [HPO:curators]
Show

 HP:0012062 Bone cyst "A fluid filled cavity that develops with a bone." [HPO:probinson]
Show

 HP:0030016 Dyspareunia "Recurrent or persistent genital pain associated with sexual intercourse." []
Show

 HP:0030142 Abnormal bowel sounds "An anomaly of the amount or nature of abdominal sounds. Abdominal sounds (bowel sounds) are made by the movement of the intestines as they promote passage of abdominal contents by peristalsis." []
Show

 HP:0100520 Oliguria "Low output of urine, clinically classified as an output below 300-500ml/day." [HPO:sdoelken]
Show

 HP:0100545 Arterial stenosis 
Show

 HP:0100578 Lipoatrophy "Localized loss of fat tissue." [HPO:sdoelken]
Show

 HP:0100579 Mucosal telangiectasiae "`Telangiectasia` (HP:0001009) of the mucosa, the mucous membranes which are involved in absorption and secretion that line cavities that are exposed to the external environment and internal organs." [HPO:sdoelken]
Show

 HP:0100585 Teleangiectasia of the skin 
Show

 HP:0100735 Hypertensive crisis 
Show

 HP:0100820 Glomerulopathy "Inflammatory or noninflammatory diseases affecting the glomeruli of the nephron." [HPO:sdoelken]
Show

 HP:0100958 Narrow foramen obturatorium 
Show

 HP:0200042 skin ulcer "A discontinuity of the skin exhibiting complete loss of the epidermis and often portions of the dermis and even subcutaneous fat." [HPO:SKOEHLER]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000080824 P07900 / HSP90AA1 / heat shock protein 90 alpha family class A member 1  / reaction / complex
 ENSG00000106299 WASL / O00401 / Wiskott-Aldrich syndrome like  / complex / reaction
 ENSG00000164867 NOS3 / P29474 / nitric oxide synthase 3  / reaction / complex
 ENSG00000198668 CALM1 / P0DP23 / calmodulin 1  / reaction / complex
 ENSG00000163072 Q8IVI9 / NOSTRIN / nitric oxide synthase trafficking  / complex / reaction
 ENSG00000079805 DNM2 / P50570 / dynamin 2  / complex / reaction
 ENSG00000172270 BSG / P35613 / basigin (Ok blood group)  / reaction / complex






 

1 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr